In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors: Studies on primary and secondary polycythemia

Cristina Montagna, P. Massaro, F. Morali, P. Foa, A. T. Maiolo, S. Eridani

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background. Primary proliferative polycythemia is a clonal disease characterized by excessive hemopoiesis and associated with a lower than normal erytropoietin plasma level; in vitro colony studies may reveal increased sensitivity of the abnormal clone to hemopoietic growth factors. Materials and methods. We studied the in vitro formation of erythroid colonies (BFU-E derived clone) in cultures set up with a serum-free medium and containing Epo, interleukin 3 (IL-3) and stem cell factor (SCF), in various combinations. The clonogenic test was performed by plating non adherent mononuclear cells from the peripheral blood of normal subjects and from patients with PPP and secondary polycythemia (SP). Results. SCF is a major amplifier of erythroid colony growth, in the presence of Epo; in cultures from PPP patients, however, the presence of SCF, in addition to Epo, enhances colony formation at about the same rate as in cultures from normal subjects. When SCF is omitted, the presence of even modest amounts of Epo and IL-3 is sufficient to obtain a statisticafiy significant difference between colony formation from PPP patients on the one side, and SP patients and normal subjects on the other. Conclusions. Our results show that in vitro culture studies may contribute an additional diagnostic criterion for distinguishing between PPP and SP in uncertain cases. It is also possible that hypersensitivity to erythropoietic factors may play a role in the pathogenetic mechanism of primary proliferative polycythemia.

Original languageEnglish (US)
Pages (from-to)311-318
Number of pages8
JournalHaematologica
Volume79
Issue number4
StatePublished - 1994
Externally publishedYes

Fingerprint

Polycythemia Vera
Stem Cell Factor
Polycythemia
Intercellular Signaling Peptides and Proteins
Interleukin-3
Clone Cells
Erythroid Precursor Cells
Serum-Free Culture Media
Blood Cells
Hypersensitivity
In Vitro Techniques
Growth

Keywords

  • BFU-E derived clone
  • erythropoietin
  • interleukin-3
  • primary proliferative polycythemia
  • stem cell factor

ASJC Scopus subject areas

  • Hematology

Cite this

In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors : Studies on primary and secondary polycythemia. / Montagna, Cristina; Massaro, P.; Morali, F.; Foa, P.; Maiolo, A. T.; Eridani, S.

In: Haematologica, Vol. 79, No. 4, 1994, p. 311-318.

Research output: Contribution to journalArticle

Montagna, Cristina ; Massaro, P. ; Morali, F. ; Foa, P. ; Maiolo, A. T. ; Eridani, S. / In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors : Studies on primary and secondary polycythemia. In: Haematologica. 1994 ; Vol. 79, No. 4. pp. 311-318.
@article{297da95356004a59ab16bdaaab741fd1,
title = "In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors: Studies on primary and secondary polycythemia",
abstract = "Background. Primary proliferative polycythemia is a clonal disease characterized by excessive hemopoiesis and associated with a lower than normal erytropoietin plasma level; in vitro colony studies may reveal increased sensitivity of the abnormal clone to hemopoietic growth factors. Materials and methods. We studied the in vitro formation of erythroid colonies (BFU-E derived clone) in cultures set up with a serum-free medium and containing Epo, interleukin 3 (IL-3) and stem cell factor (SCF), in various combinations. The clonogenic test was performed by plating non adherent mononuclear cells from the peripheral blood of normal subjects and from patients with PPP and secondary polycythemia (SP). Results. SCF is a major amplifier of erythroid colony growth, in the presence of Epo; in cultures from PPP patients, however, the presence of SCF, in addition to Epo, enhances colony formation at about the same rate as in cultures from normal subjects. When SCF is omitted, the presence of even modest amounts of Epo and IL-3 is sufficient to obtain a statisticafiy significant difference between colony formation from PPP patients on the one side, and SP patients and normal subjects on the other. Conclusions. Our results show that in vitro culture studies may contribute an additional diagnostic criterion for distinguishing between PPP and SP in uncertain cases. It is also possible that hypersensitivity to erythropoietic factors may play a role in the pathogenetic mechanism of primary proliferative polycythemia.",
keywords = "BFU-E derived clone, erythropoietin, interleukin-3, primary proliferative polycythemia, stem cell factor",
author = "Cristina Montagna and P. Massaro and F. Morali and P. Foa and Maiolo, {A. T.} and S. Eridani",
year = "1994",
language = "English (US)",
volume = "79",
pages = "311--318",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "4",

}

TY - JOUR

T1 - In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors

T2 - Studies on primary and secondary polycythemia

AU - Montagna, Cristina

AU - Massaro, P.

AU - Morali, F.

AU - Foa, P.

AU - Maiolo, A. T.

AU - Eridani, S.

PY - 1994

Y1 - 1994

N2 - Background. Primary proliferative polycythemia is a clonal disease characterized by excessive hemopoiesis and associated with a lower than normal erytropoietin plasma level; in vitro colony studies may reveal increased sensitivity of the abnormal clone to hemopoietic growth factors. Materials and methods. We studied the in vitro formation of erythroid colonies (BFU-E derived clone) in cultures set up with a serum-free medium and containing Epo, interleukin 3 (IL-3) and stem cell factor (SCF), in various combinations. The clonogenic test was performed by plating non adherent mononuclear cells from the peripheral blood of normal subjects and from patients with PPP and secondary polycythemia (SP). Results. SCF is a major amplifier of erythroid colony growth, in the presence of Epo; in cultures from PPP patients, however, the presence of SCF, in addition to Epo, enhances colony formation at about the same rate as in cultures from normal subjects. When SCF is omitted, the presence of even modest amounts of Epo and IL-3 is sufficient to obtain a statisticafiy significant difference between colony formation from PPP patients on the one side, and SP patients and normal subjects on the other. Conclusions. Our results show that in vitro culture studies may contribute an additional diagnostic criterion for distinguishing between PPP and SP in uncertain cases. It is also possible that hypersensitivity to erythropoietic factors may play a role in the pathogenetic mechanism of primary proliferative polycythemia.

AB - Background. Primary proliferative polycythemia is a clonal disease characterized by excessive hemopoiesis and associated with a lower than normal erytropoietin plasma level; in vitro colony studies may reveal increased sensitivity of the abnormal clone to hemopoietic growth factors. Materials and methods. We studied the in vitro formation of erythroid colonies (BFU-E derived clone) in cultures set up with a serum-free medium and containing Epo, interleukin 3 (IL-3) and stem cell factor (SCF), in various combinations. The clonogenic test was performed by plating non adherent mononuclear cells from the peripheral blood of normal subjects and from patients with PPP and secondary polycythemia (SP). Results. SCF is a major amplifier of erythroid colony growth, in the presence of Epo; in cultures from PPP patients, however, the presence of SCF, in addition to Epo, enhances colony formation at about the same rate as in cultures from normal subjects. When SCF is omitted, the presence of even modest amounts of Epo and IL-3 is sufficient to obtain a statisticafiy significant difference between colony formation from PPP patients on the one side, and SP patients and normal subjects on the other. Conclusions. Our results show that in vitro culture studies may contribute an additional diagnostic criterion for distinguishing between PPP and SP in uncertain cases. It is also possible that hypersensitivity to erythropoietic factors may play a role in the pathogenetic mechanism of primary proliferative polycythemia.

KW - BFU-E derived clone

KW - erythropoietin

KW - interleukin-3

KW - primary proliferative polycythemia

KW - stem cell factor

UR - http://www.scopus.com/inward/record.url?scp=0028068120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028068120&partnerID=8YFLogxK

M3 - Article

C2 - 7806084

AN - SCOPUS:0028068120

VL - 79

SP - 311

EP - 318

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -